# Genmab A/S: Form 6-K, filed Feb 3, 2026

- Company: [Genmab A/S](/companies/gmab.md) (CIK 1434265)
- Form: 6-K
- Filed: 2026-02-03
- Accepted by EDGAR: Feb 3, 2026, 11:59 ET
- Period: 2026-02-03
- Accession: 0001434265-26-000008
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1434265/000143426526000008/gmab_20260203x6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434265/000143426526000008/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434265/000143426526000008/gmab_20260203x6k.htm

Filed Feb 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001434265-26-000008. Last ingested by Listed: Nov 13, 2026, 10:58 ET. No prices; not investment advice.
